Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Never miss an Options trading signal: Unusual Options Activity and Options Screeners with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Ainos Inc (AIMD)

Ainos Inc (AIMD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 4,162
  • Shares Outstanding, K 6,503
  • Annual Sales, $ 120 K
  • Annual Income, $ -13,770 K
  • 60-Month Beta 1.38
  • Price/Sales 42.07
  • Price/Cash Flow N/A
  • Price/Book 0.24
Trade AIMD with:
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -1.92
  • Most Recent Earnings $-0.49 on 08/05/24
  • Next Earnings Date 08/09/24
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.4789 +33.64%
on 08/06/24
0.7580 -15.57%
on 08/19/24
-0.0191 (-2.90%)
since 07/30/24
3-Month
0.4789 +33.64%
on 08/06/24
1.1700 -45.30%
on 06/14/24
-0.2060 (-24.35%)
since 05/30/24
52-Week
0.4789 +33.64%
on 08/06/24
4.3200 -85.19%
on 09/15/23
-2.2300 (-77.70%)
since 08/29/23

Most Recent Stories

More News
Ainos Enrolls First Subject for Clinical Study of VELDONA-Based Animal FCGS Drug

The clinical study of new potential VELDONA-based animal drug is poised to expand VELDONA's market.

AIMD : 0.6400 (+0.31%)
Ainos Commences Shipping its VELDONA Pet Cytoprotein Supplements in Taiwan

First Batch of 300,000 Units to be Fully Delivered in October

AIMD : 0.6400 (+0.31%)
AIMDW : 0.0700 (unch)
Ainos (NASDAQ: AIMD) Enters MoU with Merdury to Explore Phase 3 Study of VELDONA

Ainos, Inc. (NASDAQ: AIMD) is engaged as a diversified medical technology company, which is focused on developing innovative point-of-care testing

AIMD : 0.6400 (+0.31%)
Ainos Publishes Preclinical Data Demonstrating its VELDONA Formulation's Potential as Treatment Candidates for the Most Common Medical Conditions for Companion Animals

/PRNewswire/ -- Ainos, Inc. (NASDAQ: AIMD, AIMDW) ("Ainos", or the "Company"), a diversified medtech company focused on the development of novel point-of-care...

AIMD : 0.6400 (+0.31%)
Ainos Reports Unaudited Third Quarter 2022 Financial Results

/PRNewswire/ -- Ainos, Inc. (NASDAQ: AIMD, AIMDW) ("Ainos", or the "Company"), a diversified medtech company focused on the development of novel point-of-care...

AIMD : 0.6400 (+0.31%)
Ainos Announces Positive Results from Preclinical Studies of Its Low-dose Oral Interferon Formulation Against COVID-19

/PRNewswire/ -- Ainos, Inc. (OTC PINK: AIMD) ("Ainos", or the "Company"), a diversified medtech company focused on the development of novel point-of-care...

AIMD : 0.6400 (+0.31%)
Ainos COVID-19 Antigen Self-Test Receives Approval for Sale in Taiwan

SAN DIEGO, CA / ACCESSWIRE / June 21, 2022 / Ainos, Inc. (OTC PINK:AIMD) ("Ainos", or the "Company"), a diversified medtech company focused on the development of novel point-of-care testing, low-dose interferon...

AIMD : 0.6400 (+0.31%)
Ainos Announces Strategic Relationship with InnoPharmax to Jointly Develop Combined Oral Therapy for Coronavirus Infection

SAN DIEGO, CA / ACCESSWIRE / December 7, 2021 / Ainos, Inc. ("we", "our", or the "company"), (OTC PINK:AIMD), a diversified healthcare company engaged in the discovery and development of pharmaceutical,...

AIMD : 0.6400 (+0.31%)
Ainos SRNA Research Initiative Announces Milestones for mRNA Vaccine Development

SAN DIEGO, CA / ACCESSWIRE / November 3, 2021 / Ainos, Inc. ("we", "our", or the "company"), (OTC PINK:AIMD), announced today that the company has recently achieved early stage milestones in its mRNA vaccine...

AIMD : 0.6400 (+0.31%)
Ainos Elects Ms. Hui-Lan (Celia) Wu as CFO, Lawrence K. Lin as Executive Vice President of Operations, and Other Key Executives

SAN DIEGO, CA / ACCESSWIRE / August 16, 2021 / Ainos, Inc. ("we", "our", or the "Company"), (OTC PINK:AIMD), elected Ms. Hui-Lan (Celia) Wu as its new Chief Financial Officer ("CFO"). Ms. Wu succeeds Mr....

AIMD : 0.6400 (+0.31%)

Business Summary

Ainos Inc. is a diversified healthcare company. It engaged in the discovery and development of pharmaceutical and biotech products. The company introduce novel products that actively stimulate and rejuvenate the human body to combat disease and enhance the ability to heal. Ainos Inc., formerly known...

See More

Key Turning Points

3rd Resistance Point 0.7165
2nd Resistance Point 0.6933
1st Resistance Point 0.6666
Last Price 0.6400
1st Support Level 0.6167
2nd Support Level 0.5935
3rd Support Level 0.5668

See More

52-Week High 4.3200
Fibonacci 61.8% 2.8527
Fibonacci 50% 2.3995
Fibonacci 38.2% 1.9462
Last Price 0.6400
52-Week Low 0.4789

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar